News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Weather
E-Edition
Subscribe
Sign Up For Newsletters
News
News
Local News
Crime & Public Safety
Your Tax Dollars At Work
Politics
Massachusetts
Nation
World
Business
Health
Weather
Columnists
Traffic
Sports
Sports
Red Sox
Patriots
Celtics
Bruins
College
High School
More Sports
Scores & Stats
Entertainment
Entertainment
Celebrity News
Arts & Culture
Movies
Television
Music
Fun & Games
Horoscope
Lottery
Comics
Puzzles
Lifestyle
Lifestyle
Food & Beverage
Travel
Style & Fashion
Obituaries
Obituaries
Local Obituaries
Submit an Obituary
Opinion
Opinion
Editorials
Op-Ed
Letters
Submit a Letter
Radio
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by ENDRA Life Sciences Inc.
< Previous
1
2
Next >
ENDRA Life Sciences Announces 1-for-20 Reverse Stock Split
December 05, 2022
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Reports Third Quarter 2022 Financial Results and Provides Business Update
November 14, 2022
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences to Report Third Quarter 2022 Financial Results on November 14, 2022
November 09, 2022
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Enhances TAEUS® System Intellectual Property Portfolio with Issuance of Two U.S. Patents
October 25, 2022
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences to Participate in the H.C. Wainwright 6th Annual NASH Investor Conference
October 04, 2022
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Plans to Submit De Novo Request to U.S. FDA for its TAEUS® System in Coming Weeks
September 29, 2022
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences to Participate in Upcoming Investor and Industry Conferences
September 06, 2022
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Announces Issuance of 8th European Patent for its TAEUS® System
August 24, 2022
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Reports Second Quarter 2022 Financial Results and Provides Business Update
August 15, 2022
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences to Report Second Quarter 2022 Financial Results on August 15, 2022
August 04, 2022
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Awarded Three Additional U.S. Patents for Cloud-enabled Connectivity of Medical Devices
August 02, 2022
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences to Participate in the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference
August 01, 2022
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Enhances TAEUS® System Intellectual Property Portfolio with Issuance of 28th U.S. Patent
June 28, 2022
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences to Participate in the JMP Securities Life Sciences Conference
June 08, 2022
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Bolsters TAEUS® System Intellectual Property with Issuance of 27th U.S. Patent
May 25, 2022
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences to Present at the H.C. Wainwright Global Investment Conference
May 16, 2022
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Reports First Quarter 2022 Financial Results and Provides Business Update
May 12, 2022
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Issued Additional U.S. and Chinese Patents for its TAEUS® System
May 10, 2022
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences to Report First Quarter 2022 Financial Results on May 12, 2022
May 02, 2022
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Raises $8.7 Million in Gross Proceeds Through its At-The-Market Facility
April 21, 2022
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Achieves Key Quality Management System Certification
March 31, 2022
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
March 30, 2022
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Strengthens TAEUS® System Global Intellectual Property Protection with Issuance of 10th and 11th Chinese Patents
March 30, 2022
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences to Report Fourth Quarter 2021 Financial Results on March 30, 2022
March 22, 2022
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Strengthens TAEUS® System Global Intellectual Property Portfolio with Issuance of 6th and 7th European Patents
February 11, 2022
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Provides Update on U.S. Regulatory Strategy for its TAEUS® System
February 09, 2022
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Expands into China with Shanghai General Hospital Partnership
January 24, 2022
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences to Present at the H.C. Wainwright BioConnect Virtual Conference
January 05, 2022
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Announces New Clinical Study Partnership with King’s College Hospital, London
December 13, 2021
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
ENDRA Life Sciences Expands Pharmaceutical Partnerships with VGI Health Technology to Provide TAEUS for Patient Screening and Biomarker Measurement for Phase 2 Study
November 29, 2021
From
ENDRA Life Sciences Inc.
Via
Business Wire
Tickers
NDRA
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Close